Antonella Cordoba/LinkedIn
Aug 9, 2026, 15:16
Antonella Cordoba: Emicizumab and the Evolving Landscape of Hemophilia A
Antonella Cordoba, Médica Hematologa at Hospital General de Agudos José Maria Penna, shared a post on LinkedIn:
”The meeting organized by Roche on Hemlibra (emicizumab) and the new advances in the treatment of hemophilia A was very enriching.
A space for updating and exchange on how innovation continues to transform the approach to hemorrhagic diseases.
Thank you Guillermo Rabossi for the invitation and for generating these learning spaces.”
-
Aug 9, 2026, 15:33Tareq Abadl: Kell System and Anti-K Alloimmunization
-
Aug 9, 2026, 14:53Daniel Pereira Monteiro: Understanding Isoelectric Focusing in Hemoglobin Testing
-
Aug 9, 2026, 14:23Retheesh Das։ Edema Is a Sign, Not a Diagnosis
-
Aug 9, 2026, 13:56Binay Shah: Building a Future of Accessible Cancer Care
-
Aug 9, 2026, 13:44Taking Charge of Your Bleeding Disorder – National Bleeding Disorders Foundation
-
Aug 9, 2026, 13:17Andrew Zapfel: Building a Stronger Future for Sickle Cell Care in Kenya
-
Aug 9, 2026, 13:07Angelica Varesi: New Insights into Hematopoietic Stem Cell Biology
-
Aug 9, 2026, 12:48Paul Watton։ New Clues to the Cause of ME/CFS
-
Aug 9, 2026, 12:26Mohamed Rawy: When Is a Reduced DOAC Dose Appropriate?